2014 News

Craik named a fellow of National Academy of Inventors

Charles Craik, PhD, whose innovative research has generated ten patents and helped launch two companies, has been named a fellow by the National Academy of Inventors (NAI).

Most recent School of Pharmacy primary faculty hires, by department

The most recently hired faculty members to join the UCSF School of Pharmacy have research interests that range from the treatment of blood clots to mapping biological networks in cancer cells to understanding the molecular workings of ion channels in cell membranes. But they all share the common purpose of ultimately discovering new ways to better address disease through therapeutics. These eight are now at work in the School’s three departments.

Study finds depression in pregnancy, postpartum is overlooked and undertreated

About 10 to 20 percent of women suffer from new-onset depression during pregnancy or after giving birth. Untreated, the impact of such illness can be profound, ranging from substance abuse, poor prenatal care, and miscarriages to impaired infant bonding and developmental delays.

Desai lab develops nano-devices to aid artery repair

Research in the laboratory of Tejal Desai, PhD, is creating new kinds of drug delivery devices to reduce the scarring and inflammation that can undermine stents—metal mesh tubes implanted to prop open blocked arteries, including in the heart.

Class of 2018 student pharmacists put on their white coats

The students of the UCSF School of Pharmacy’s incoming class—whose countries of origin range from Rwanda to Iran and who hold degrees in subjects from biology to biochemistry and from psychology to accounting—put on their white coats for the first time on October 10, 2014, in an afternoon ceremony signaling their entry into the profession.

Burchard study finds Latino asthma risk varies with genetic ancestry

A new analysis of nearly 5,500 Latino children with and without asthma led by School scientists has found that variations in their genetic ancestry can partially explain major differences in their risk of developing the disease.

Burchard commentary calls for more diversity in biomedical research

Authoring the lead commentary in the current special issue of Nature devoted to diversity, School faculty member Esteban Burchard, MD, MPH, asserts that the clinical and biomedical research infrastructure “needs to be retooled” to include more diverse patient populations in studies.

Update from the Dean - Fall/Winter 2014

Strategic planning, research funding: Savic, Fischbach, Huang; recent publications: Wells, Giacomini, Savic, Desai; patient care: OneUCSF Pharmacy: Wandres, formulary review: Brodowy, Tsourounis, VanOsdol; MedList Clinic: Stebbins, Cocohoba, Kroon, Lee, Rodondi, Youmans; automated system: Stebbins, Lee; SB 493: Kroon, Corelli, Stebbins, Rodondi, Cocohoba; education: Youmans; programs: The Kidney Project (Roy), CERSI (Giacomini, Altman); honors: Cocohoba, Kroetz, Fong, Barcelon, Shahrooz-Foo, Wong, Yokokura, Komoto, Hristeva, Benet, Schweitzer, Ignoffo); new faculty members: Tamraz, Grabe, Keiser, Wu, Altschuler; new BTS chair: Desai; history: Ilieva, Day, Benet, Way, Schmidt; new chancellor: Hawgood.

Tejal Desai named chair of the Department of Bioengineering and Therapeutic Sciences

Tejal Desai, PhD, has been named the new chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and Medicine. Her appointment is effective August 1, 2014.

Napolitano selects Hawgood as next UCSF Chancellor

University of California President Janet Napolitano has announced that her choice for the 10th chancellor of UC San Francisco is Sam Hawgood, MBBS, the UCSF School of Medicine dean who has served as interim UCSF chancellor since April 1. The UC Board of Regents will vote on Napolitano’s selection and the terms of the appointment on July 17.

Retreat kicks off major revision of School curriculum

The UCSF School of Pharmacy, a leader in pharmacy education worldwide, jump-started a transformation of its Doctor of Pharmacy (PharmD) curriculum at a Schoolwide meeting on June 18, 2014 at the Presidio of San Francisco.

School leaders, staff, students step out in support of AIDS Walk San Francisco

The entire UCSF enterprise—including the School of Pharmacy—is gearing up for AIDS Walk San Francisco. This year’s walk will take place on Sunday, July 20 in Golden Gate Park.

Major Mexican genetic study uncovers basis for health differences among Latinos

The most comprehensive genetic study of the Mexican population to date has revealed as much genetic differentiation as the variation between some Europeans and Asians.

Burlingame and Gross labs shed light on braking mechanisms in cellular signaling

How do cells that must respond rapidly and robustly to changes in the environment subsequently modulate that response so such elevated activity doesn’t prove harmful? Put another way: How do cells put the brakes on their response to external signaling in order to re-stabilize themselves?

Label warnings, antibiotic measurements, cancer therapies, and smoking interventions take top honors at annual seminar

Studies of improved over-the-counter acetaminophen warning labels, more accurate measurements of antibiotics in hospitalized patients, therapies for metastatic breast cancer, and methods for training pharmacy personnel to help smokers quit took top honors at the Department of Clinical Pharmacy’s 16th Annual Spring Research Seminar.

FDA launches UCSF-Stanford center for innovation in drug development, regulation

The U.S. Food and Drug Administration (FDA) is tapping the UCSF School of Pharmacy and Stanford University to launch its first West Coast regulatory science center, focused on spurring innovation in the development and evaluation of safer and more effective medications.

The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI) has been formally launched with an initial FDA grant of $3.3 million.

Update from the Dean - Spring/Summer 2014

Survey results; Strategic planning, retreat results and education; Recently received research funding (Szoka, Wells, Bandyopadhyay); Recent faculty publications (Kortemme, Renslo and Arkin, Van Osdol and Tsourounis); SB 493: Pharmacist provider status legislation; Walgreens at UCSF; Safeway partnership; Honors (Fraser, Gartner, Oppenheimer, Schweitzer, Tong, Penick Brock); New holders of endowed chairs (Cutler, Kroon); Student honors (Yokoyama, Cheung, Du, Fong, Lee); 30 Under 30 (Ostrem); Accreditation status; UCSF anniversary; Homecoming; New colleagues (Samuel, Gunning, Katsuura); Campus (Napolitano, Desmond-Hellmann, Hawgood).

James Fraser named Searle Scholar, will shine new light on protein shapeshifting

Biophysicist James Fraser, PhD, has been named a 2014 Searle Scholar. His laboratory will be awarded $300,000 in funding over the next three years to support his research into more accurately and precisely describing the ways that protein molecules change shape to carry out the functions of life in our bodies.

A MedList clinic: perspectives of a pharmacist and a student pharmacist

UCSF, Walgreens open pharmacy to jointly explore new models of care

A unique new pharmacy developed to explore more effective models of medication management and pharmacist-based patient care, improving drug safety and efficacy by reducing medication errors and lapses, officially opened with a ribbon cutting on the Parnassus campus on Tuesday.

“Walgreens at UCSF,” located across the street from UCSF Medical Center, is a joint effort between the nation’s largest drug store chain, the UCSF School of Pharmacy, and the Medical Center.

UCSF School of Pharmacy leads in NIH funding for 34th year in a row

For the 34th consecutive year, the UCSF School of Pharmacy has received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

School researchers were awarded $29.2 million during the 2013 NIH fiscal year, from October 1, 2012 to September 30, 2013.

UCSF team wins $2.7 million for innovative project to reduce premature births

A research team including co-principal investigators Shuvo Roy, PhD, and Mozziyar Etemadi, PhD, who trained in Roy’s lab, has been awarded a three-year $2.7 million grant from the Bill and Melinda Gates Foundation to further develop a remote monitoring and early warning system to reduce premature births.

Analysis finds sponsorship biases in animal studies may differ from those in clinical trials

A new analysis of dozens of animal studies evaluating the effects of the cholesterol-lowering statin class of drugs on atherosclerosis found larger positive effects in studies not sponsored by the pharmaceutical industry as compared to those that were industry sponsored.